Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Moderate Buy” by Brokerages

Health Catalyst, Inc. (NASDAQ:HCAT) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $12.50.

Several equities analysts recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $15.00 price objective (down previously from $17.00) on shares of Health Catalyst in a research note on Friday, February 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research report on Tuesday, March 5th. Barclays started coverage on shares of Health Catalyst in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $14.00 price target for the company. Evercore ISI dropped their price target on shares of Health Catalyst from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, February 23rd. Finally, JPMorgan Chase & Co. raised shares of Health Catalyst from a “neutral” rating to an “overweight” rating and dropped their price objective for the stock from $14.00 to $11.00 in a research report on Wednesday, December 13th.

Insider Activity at Health Catalyst

In related news, insider Linda Llewelyn sold 3,163 shares of the firm’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $10.83, for a total transaction of $34,255.29. Following the completion of the sale, the insider now directly owns 68,048 shares of the company’s stock, valued at approximately $736,959.84. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On Health Catalyst

Large investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its holdings in Health Catalyst by 124.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company’s stock valued at $8,652,000 after purchasing an additional 473,323 shares in the last quarter. MQS Management LLC bought a new position in Health Catalyst during the 3rd quarter valued at $116,000. Shell Asset Management Co. bought a new position in Health Catalyst during the 3rd quarter valued at $195,000. Jefferies Financial Group Inc. bought a new position in Health Catalyst during the 2nd quarter valued at $1,000,000. Finally, Hsbc Holdings PLC boosted its stake in Health Catalyst by 266.8% during the 3rd quarter. Hsbc Holdings PLC now owns 41,420 shares of the company’s stock valued at $411,000 after acquiring an additional 30,127 shares during the last quarter. 86.63% of the stock is owned by institutional investors and hedge funds.

Health Catalyst Stock Performance

Shares of HCAT opened at $7.49 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 4.42 and a current ratio of 4.42. The company has a market capitalization of $438.64 million, a price-to-earnings ratio of -3.57 and a beta of 1.30. The company’s 50 day simple moving average is $9.07 and its 200 day simple moving average is $8.89. Health Catalyst has a 1 year low of $6.60 and a 1 year high of $14.37.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.06. The business had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. Health Catalyst had a negative net margin of 39.92% and a negative return on equity of 12.19%. On average, sell-side analysts predict that Health Catalyst will post -0.47 EPS for the current year.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.